Delivery Order SPE2DX15D0020-B080
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Cardinal Health, Inc. The contract, valued at $3,171.73, is for the provision of pharmaceutical products and medical supplies as part of the DLA's Pharmaceutical Prime Vendor program. This program supplies a wide range of medical products, including prescription medications, vaccines, and radiopharmaceuticals, to military treatment facilities and deployed troops...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $117,808.21 firm fixed-price delivery order is part of the DLA's Pharmaceutical Prime Vendor program, which supplies a comprehensive range of medical products to military treatment facilities and deployed troops worldwide. The contract has no set-aside designation, reflecting Cardinal Health's status as a large, for-profit corporation....
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Cardinal Health, Inc. to the U.S. government. The contract, valued at $1,657.36, is a delivery order awarded under the Defense Logistics Agency's (DLA) Pharmaceutical Prime Vendor program, which supplies a wide range of medical products to military treatment facilities and deployed troops worldwide. Cardinal Health, a global healthcare services and products company, has a long-standing...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $1,300.26 firm-fixed-price delivery order is for the Pharmaceutical Prime Vendor Fleet program, which supplies a comprehensive range of medical products to military treatment facilities and deployed troops worldwide. Cardinal Health, operating as Cardinal Health Inc. Division and doing business as Cardinal Health, has a long-standing...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $5,801.99, is for the delivery of pharmaceutical products to the U.S. government, specifically to military treatment facilities and deployed troops worldwide under the DLA Pharmaceutical Prime Vendor program. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting Cardinal Health's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $8,883.87 firm-fixed-price delivery order is for the Pharmaceutical Prime Vendor Fleet program, which provides a comprehensive range of pharmaceutical and medical products to military treatment facilities and deployed troops worldwide. The contract has no set-aside designation, reflecting Cardinal Health's status as a large, for-profit...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services company. The award, with a ceiling value of $121,308.02, is for the delivery of pharmaceutical products to support the DLA's Pharmaceutical Prime Vendor program. This program provides a comprehensive range of medical supplies, including prescription medications, vaccines, and other consumables, to military treatment facilities and deployed troops worldwide....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $2,934.71 firm fixed-price delivery order is for the Pharmaceutical Prime Vendor Fleet program, which supplies a comprehensive range of medical products to military treatment facilities and deployed troops worldwide. Cardinal Health, a long-standing federal contractor, has provided pharmaceutical distribution services to the Department of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $128,604.23 firm fixed-price delivery order is part of the DLA's Pharmaceutical Prime Vendor program, which supplies a range of medical products to military treatment facilities and deployed troops worldwide. The contract has no set-aside designation, reflecting Cardinal Health's status as a large, for-profit corporation. Cardinal Health...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a major healthcare services and products company. The $4,049.32 firm fixed-price delivery order is part of the DLA's Pharmaceutical Prime Vendor program, which supplies a wide range of pharmaceutical and medical products to military treatment facilities and deployed troops worldwide. The contract has no set-aside designation, reflecting Cardinal Health's status as a large, for-profit...
- SPE2DX15D0020Indefinite Delivery Contract
- SPE2DX15D0020-B080Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services and products company. The $453,605.94 firm fixed-price delivery order is part of the DLA's Pharmaceutical Prime Vendor program, which supplies a comprehensive range of medical products to military treatment facilities and deployed troops worldwide. Cardinal Health has a long-standing relationship with government procurement, having been registered to receive federal awards since 2001. The contract has no set-aside designation. In addition to this delivery order, Cardinal Health holds a separate $773,677.24 indefinite delivery contract with the Department of Veterans Affairs (VA) for the provision of radiopharmaceutical products to support medical imaging procedures within the VA healthcare system. The company's subsidiary, The Harvard Drug Group, L.L.C., also has a $10,056,938.10 single-award indefinite delivery contract with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $453.6k | 4/20/16 |